Tag: Institut Pasteur de Dakar

  • Rapid Molecular Detection of Yellow Fever Virus at the Point of Care

    Rapid Molecular Detection of Yellow Fever Virus at the Point of Care

    Senegal | Infectious diseases | Rapid diagnostics

    This project team at the Institut Pasteur de Dakar is developing a point of care rapid diagnostic test for the molecular detection of the Yellow Fever virus. This initiative aims to enable timely diagnosis and effective outbreak management by providing quick results in clinical settings.  By raising awareness and integrating this technology into healthcare facilities, the project seeks to strengthen the surveillance and response systems for Yellow Fever in Senegal, particularly in high-risk areas.

  • Combination of Biomarker Detection and Metagenomic Sequencing for Viral Surveillance in Kedougou, Eastern Senegal

    Combination of Biomarker Detection and Metagenomic Sequencing for Viral Surveillance in Kedougou, Eastern Senegal

    Senegal | Viral infections | Diagnostics innovation

    The Institut Pasteur de Dakar is advancing viral surveillance in Kedougou through this innovation which combines biomarker detection with metagenomic sequencing. This project aims to enhance the detection of viral infections while optimizing resource use through better sample selection. By implementing a rapid diagnostic test focused on specific viral markers, the initiative strives to improve public health interventions and reduce the impact of viral outbreaks in the region. Training healthcare workers on the use of these advanced diagnostics will ensure timely identification of viral infections and facilitate appropriate responses.

  • Development of a Rapid Molecular Detection Test for Measles Virus Diagnosis

    Development of a Rapid Molecular Detection Test for Measles Virus Diagnosis

    Senegal | Infectious diseases | Diagnostics innovation

    At the Institut Pasteur de Dakar, the project team are developing a rapid molecular diagnostic test for measles on lateral flow strips and in cassette form, using CRISPR technology, previously used mainly in the field of genome editing. The end product will enable rapid, highly sensitive diagnosis, and could potentially offer a cheaper alternative to current diagnostic methods in the future. This will significantly boost the level of measles virus surveillance, particularly in low-resource environments. The team plans to validate the test across various healthcare settings, ensuring its accessibility and reliability, and will conduct training for healthcare professionals to facilitate prompt and accurate diagnoses.

Contact us:
grandchallenges.senegal@pasteur.sn